INSIDER · CIK 2020969
Khan Najat
CEO and President, Director at RECURSION PHARMACEUTICALS, INC. (RXRX)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$79KSold on the market
1Companies
Sep 10, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 202617:55 | Sep 8, 2026 | RXRXRECURSION PHARMACEUTICALS, INC. | CEO and President, Director | S · Sell10b5-1 | $3.52 | −22,408 | 2,072,890 | -1% | −$79K | ||
| Aug 18, 202617:44 | Aug 17, 2026 | RXRXRECURSION PHARMACEUTICALS, INC. | CEO and President, Director | F · Tax | $3.16 | −80,498 | 2,095,298 | -4% | $254K |